Reply to correspondence on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C".

Journal

Clinical and molecular hepatology

Journal Volume

31

Journal Issue

2

Pages

e232 - e233

ISSN

2287-285X

Date Issued

2025-04

Author(s)

DOI

URI

Subjects

Direct-acting antiviral

Hepatic fibrosis

Hepatitis C

Noninvasive test

Sustained virologic response

Type

journal article